OPEN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
OPEN is not a good buy right now for an impatient investor. The stock is trading weak in pre-market (~$5.50, -1.43%) and sits below a key support zone (S1 ~5.64) with bearish momentum (MACD histogram negative and expanding). With no Intellectia buy signals today, heavy hedge-fund selling, and recent Congress activity skewed to selling, the risk/reward favors avoiding new entries (or trimming) until price reclaims the ~$5.64–$6.18 area decisively.
Trend/Momentum: Bearish near-term. MACD histogram is -0.0806 and negatively expanding, signaling strengthening downside momentum. RSI(6) ~24.44 indicates the stock is oversold (bounce risk exists), but oversold alone is not a buy trigger when momentum is still deteriorating. Key Levels: Pivot ~6.183 is the key reclaim level for trend improvement. Immediate support S1 ~5.641 is already broken in pre-market (5.50), making S2 ~5.305 the next notable downside level. Resistance levels: R1 ~6.725 and R2 ~7.061. Interpretation: Price under S1 + bearish MACD suggests sellers remain in control. A short-lived oversold bounce is possible, but the technical setup does not favor chasing a “buy now” entry.
Intellectia Proprietary Trading Signals
suggests market participants are positioned more for upside than downside (though not confirmed by volume today).
in pre-market with bearish MACD expansion.
on 2026-02-23 after hours; could amplify volatility and downside if guidance/disclosures disappoint.
Latest quarter: 2025/Q3. Revenue was $915M, down -33.55% YoY (clear top-line contraction). Net income improved YoY to -$90M (still a loss, but narrower by ~15.38%). EPS improved to -$0.12 (about +9.09% YoY). Gross margin fell to 7.21% (-5.50% YoY), indicating profitability quality weakened even as losses narrowed. Overall: cost/loss improvement exists, but the growth trend is negative and margins remain thin for a capital-intensive model.
Recent trend: Price targets were lifted off very depressed levels after the Q3 report/new management narrative, but ratings remain mixed-to-cautious. Deutsche Bank raised PT to $4 (Hold). Citi raised PT to $1.40 but kept Sell. JPMorgan initiated/kept Overweight with an $8 PT (most bullish among listed). Keefe Bruyette raised PT to $2 but stayed Underperform. BTIG remained Neutral and argued ~$5/share is roughly fair under optimistic volume/margin assumptions. Wall Street pros: New leadership energy, potential scaling acceleration if spreads/pricing improve, upside optionality if housing liquidity improves. Wall Street cons: Capital-intensive, low-margin model; execution risk in “buying more homes faster at better margins”; revenue declines and ongoing losses; upside cases require aggressive assumptions.
